Hemi Dimant - Publications

Affiliations: 
2010-2013 Neurology Massachusetts General Hospital, Boston, MA 

7/11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Hudry E, Martin C, Gandhi S, György B, Scheffer DI, Mu D, Merkel SF, Mingozzi F, Fitzpatrick Z, Dimant H, Masek M, Ragan T, Tan S, Brisson AR, Ramirez SH, et al. Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Therapy. PMID 26836117 DOI: 10.1038/Gt.2016.11  0.342
2014 Dimant H, Zhu L, Kibuuka LN, Fan Z, Hyman BT, McLean PJ. Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics. Plos One. 9: e92098. PMID 24664141 DOI: 10.1371/Journal.Pone.0092098  0.706
2014 McFarland NR, Dimant H, Kibuuka L, Ebrahimi-Fakhari D, Desjardins CA, Danzer KM, Danzer M, Fan Z, Schwarzschild MA, Hirst W, McLean PJ. Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss. Plos One. 9: e86048. PMID 24465863 DOI: 10.1371/Journal.Pone.0086048  0.675
2013 Dimant H, Kalia SK, Kalia LV, Zhu LN, Kibuuka L, Ebrahimi-Fakhari D, McFarland NR, Fan Z, Hyman BT, McLean PJ. Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathologica Communications. 1: 6. PMID 24252244 DOI: 10.1186/2051-5960-1-6  0.671
2012 Dimant H, Ebrahimi-Fakhari D, McLean PJ. Molecular chaperones and co-chaperones in Parkinson disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 18: 589-601. PMID 22829394 DOI: 10.1177/1073858412441372  0.646
2010 Dimant H, Solomon B. Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cells. Neuro-Degenerative Diseases. 7: 203-5. PMID 20224286 DOI: 10.1159/000295664  0.445
2009 Dimant H, Sharon N, Solomon B. Modulation effect of filamentous phage on alpha-synuclein aggregation. Biochemical and Biophysical Research Communications. 383: 491-6. PMID 19379715 DOI: 10.1016/J.Bbrc.2009.04.048  0.337
Low-probability matches (unlikely to be authored by this person)
2019 Mazur C, Powers B, Zasadny K, Sullivan JM, Dimant H, Kamme F, Hesterman J, Matson J, Oestergaard M, Seaman M, Holt RW, Qutaish M, Polyak I, Coelho R, Gottumukkala V, et al. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. Jci Insight. 4. PMID 31619586 DOI: 10.1172/Jci.Insight.129240  0.195
2009 Dimant H, Sharon N, Solomon B. P3.004 Modulation of alpha synuclein aggregation by fllamentous phages Parkinsonism & Related Disorders. 15: S148. DOI: 10.1016/S1353-8020(09)70568-1  0.114
2004 Dahan A, Dimant H, Portnoy M. Synthesis of tetrafurcated dendritic units on solid support. Journal of Combinatorial Chemistry. 6: 305-7. PMID 15132588 DOI: 10.1021/Cc0340630  0.114
2010 Orgad S, Dimant H, Dor-On E, Azriel-Rosenfeld R, Benhar I, Solomon B. TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 146-54. PMID 20139776 DOI: 10.1097/Cji.0B013E3181Be14Dc  0.05
Hide low-probability matches.